tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

CCXI

AMGEN SUCCESSFULLY COMPLETES ACQUISITION OF CHEMOCENTRYX
Press ReleasesAMGEN SUCCESSFULLY COMPLETES ACQUISITION OF CHEMOCENTRYX
1y ago
AMGN
CCXI
ChemoCentryx Announces Presentations at the 2022 American Society of Nephrology and American College of Rheumatology Annual Meetings
PremiumPress Releases
ChemoCentryx Announces Presentations at the 2022 American Society of Nephrology and American College of Rheumatology Annual Meetings
2y ago
CCXI
ChemoCentryx Announces Upcoming Presentations for Orally Administered PD-L1 Inhibitor, CCX559, at the 2022 Society for Immunotherapy of Cancer (SITC) Annual Meeting
PremiumPress Releases
ChemoCentryx Announces Upcoming Presentations for Orally Administered PD-L1 Inhibitor, CCX559, at the 2022 Society for Immunotherapy of Cancer (SITC) Annual Meeting
2y ago
CCXI
ChemoCentryx Announces TAVNEOS® (avacopan) Presentations at Upcoming Medical Conferences
PremiumPress Releases
ChemoCentryx Announces TAVNEOS® (avacopan) Presentations at Upcoming Medical Conferences
2y ago
CCXI
ChemoCentryx Cancels Second Quarter 2022 Financial Results Conference Call
PremiumPress Releases
ChemoCentryx Cancels Second Quarter 2022 Financial Results Conference Call
2y ago
CCXI
AMGEN TO ACQUIRE CHEMOCENTRYX FOR $4 BILLION IN CASH
PremiumPress ReleasesAMGEN TO ACQUIRE CHEMOCENTRYX FOR $4 BILLION IN CASH
2y ago
AMGN
CCXI
Can ChemoCentryx Control Challenging Capital Complications?
PremiumStock Analysis & Ideas
Can ChemoCentryx Control Challenging Capital Complications?
2y ago
CCXI
These Stocks are the Biggest Pre-Market Movers on Wednesday
PremiumMarket News
These Stocks are the Biggest Pre-Market Movers on Wednesday
2y ago
JWN
CCXI
ChemoCentryx: Can Pharma Company Hit Big?
PremiumStock Analysis & Ideas
ChemoCentryx: Can Pharma Company Hit Big?
2y ago
CCXI
Wells Fargo Pounds the Table on ChemoCentryx Stock
PremiumStock Analysis & Ideas
Wells Fargo Pounds the Table on ChemoCentryx Stock
2y ago
CCXI
ChemoCentryx Stock Is a Highly Speculative Bet
PremiumStock Analysis & Ideas
ChemoCentryx Stock Is a Highly Speculative Bet
2y ago
CCXI
ChemoCentryx Q3 Results Surpass Expectations; Street Says Buy
PremiumMarket News
ChemoCentryx Q3 Results Surpass Expectations; Street Says Buy
2y ago
CCXI
ChemoCentryx Stock: Worth Keeping an Eye on
PremiumStock Analysis & IdeasChemoCentryx Stock: Worth Keeping an Eye on
3y ago
CCXI
3 ‘Strong Buy’ Stocks Raymond James Predicts Will Rally Over 60%
PremiumStock Analysis & Ideas
3 ‘Strong Buy’ Stocks Raymond James Predicts Will Rally Over 60%
3y ago
CCXI
IIIV
Keep on Buying Chemocentryx Stock, Says Analyst Following FDA Approval
PremiumStock Analysis & Ideas
Keep on Buying Chemocentryx Stock, Says Analyst Following FDA Approval
3y ago
CCXI
ChemoCentryx Receives FDA Approval for TAVNEOS; Shares Skyrocket
PremiumMarket News
ChemoCentryx Receives FDA Approval for TAVNEOS; Shares Skyrocket
3y ago
CCXI
Chemocentryx: A Risky Yet Potentially Lucrative Bet
PremiumStock Analysis & Ideas
Chemocentryx: A Risky Yet Potentially Lucrative Bet
3y ago
CCXI
Is Chemocentryx Stock a Buy Right Now? This Is What You Need to Know
PremiumStock Analysis & Ideas
Is Chemocentryx Stock a Buy Right Now? This Is What You Need to Know
3y ago
CCXI
ChemoCentryx Releases Avacopan Trial Results For Rare Kidney Disease; Shares Plunge 8%
PremiumMarket News
ChemoCentryx Releases Avacopan Trial Results For Rare Kidney Disease; Shares Plunge 8%
3y ago
CCXI
3 “Perfect 10” Healthcare Stocks That Have Plenty of Growth on Tap
PremiumStock Analysis & Ideas3 “Perfect 10” Healthcare Stocks That Have Plenty of Growth on Tap
4y ago
CCXI

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >